Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001012477-24-000017
Filing Date
2024-08-08
Accepted
2024-08-08 09:25:44
Documents
66
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q avdl-20240630.htm   iXBRL 10-Q 1016660
2 EX-31.1 exhibit311q22024.htm EX-31.1 10846
3 EX-31.2 exhibit312q22024.htm EX-31.2 10650
4 EX-32.1 exhibit321q22024.htm EX-32.1 5723
5 EX-32.2 exhibit322q22024.htm EX-32.2 5554
  Complete submission text file 0001012477-24-000017.txt   4947217

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avdl-20240630.xsd EX-101.SCH 30473
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avdl-20240630_cal.xml EX-101.CAL 64550
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avdl-20240630_def.xml EX-101.DEF 117892
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avdl-20240630_lab.xml EX-101.LAB 430379
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avdl-20240630_pre.xml EX-101.PRE 288063
68 EXTRACTED XBRL INSTANCE DOCUMENT avdl-20240630_htm.xml XML 621329
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37977 | Film No.: 241186377
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)